Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Ginkgo Bioworks Holdings, Inc. Banner

Ginkgo Bioworks Holdings, Inc.

DNA Stock Analysis

Page title

Section title

Breakdown
2001
2019
2020
2021
2022
2023
Net Income
-2.106b-119.857m-126.723m-1.837b-2.106b-892.869m
Depreciation & Amortization
44.423M10.755M13.864M29.076M44.423M71.554M
Change in Working Capital
55.024M10.577M-26.515m-61.537m-37.006m29.837M
Operating Cash Flow
-145.917m-44.663m-135.830m-253.818m-252.198m-295.500m
Capital Expenditure
0.000-22.219m-57.821m-56.521m-52.271m-40.801m
Free Cash Flow
-145.917m-66.882m-193.651m-310.339m-304.469m-336.301m
Debt Repayment
0.000-828.000k-748.000k-1.123m-1.237m-1.295m
Dividends Paid
0.0000.0000.0000.0000.0000.000
Common Stock Issued
0.0000.00091.066M1.510B99.303M-487.000k
Common Stock Repurchased
0.000-408.000k0.000-24.998m-981.000k-23.000k
Net Change in Cash
-145.917m291.120M-112.633m1.207B-223.347m-375.151m